Oncology
Conference Coverage
Novel calculator predicts cancer risk in patients with CVD
Individual lifetime total cancer risk ranges from 1% to 52%.
Conference Coverage
Higher death rate seen in cancer patients with nosocomial COVID-19
All-cause mortality was higher in cancer patients with hospital-acquired COVID-19 than in those with community-acquired COVID-19.
From the Journals
American Cancer Society update: ‘It is best not to drink alcohol’
Feature
Patient-focused precautions, testing help blunt pandemic effects on heme-onc unit
Multiple factors helped keep the anticipated COVID-19 surge manageable at the hematologic oncology service of Levine Cancer Institute.
Opinion
Summary of the IDSA guidelines on the diagnosis of COVID-19
Learn about those recommendations that are most relevant to primary care clinicians.
Latest News
COVID-19 will likely change docs’ incentive targets, bonuses: Survey
Productivity benchmarks for physicians are likely to be lowered in light of plunging patient numbers from COVID-19, and bonuses are expected to...
From the Journals
Androgens may explain male vulnerability to COVID-19
Conference Coverage
Antitumor treatment may increase risk of severe events in COVID-19 patients
Feature
Home-based chemo skyrockets at one U.S. center
The University of Pennsylvania’s home-based chemotherapy program experienced a 300% increase in participation in a 5-week period.
Latest News
NCCN panel: Defer nonurgent skin cancer care during pandemic
The group’s melanoma recommendations focused on deferring nonurgent care until after the pandemic passes.
From the Journals
‘Brutal’ plan to restrict palliative radiation during pandemic
New guidelines recommend giving palliative radiotherapy only in oncologic emergencies during the COVID-19 pandemic.